USGS Science⌕ Search

USGS · 1008359

Clinical disease and laboratory abnormalities in free-ranging desert tortoises in California (1990-1995)

Abstract

Desert tortoise ( Gopherus agassizii ) populations have experienced precipitous declines resulting from the cumulative impact of habitat loss and human and disease-related mortality. Diagnosis of disease in live, free-ranging tortoises is facilitated by evaluation of clinical signs and laboratory test results but may be complicated by seasonal and environmental effects. The goals of this study were: 1) to describe and monitor clinical and laboratory signs of disease in adult, free-ranging desert tortoises at three sites in the Mojave Desert of California (USA) between October 1990 and October 1995; 2) to evaluate associations between clinical signs and hematologic, biochemical, serologic, and microbiologic test results; 3) to characterize disease patterns by site, season, and sex; and 4) to assess the utility of diagnostic tests in predicting morbidity and mortality. Venous blood samples were obtained four times per year from tortoises of both sexes at the Desert Tortoise Research Natural Area (DTNA), Goffs/Fenner Valley, and Ivanpah Valley. Tortoises were given a physical examination, and clinical abnormalities were graded by type and severity. Of 108 tortoises, 68.5% had clinical signs of upper respiratory tract disease consistent with mycoplasmosis at least once during the study period. In addition, 48.1% developed moderate to severe shell lesions consistent with cutaneous dyskeratosis. Ulcerated or plaque-like oral lesions were noted on single occasions in 23% of tortoises at Goffs and 6% of tortoises at Ivanpah. Tortoises with oral lesions were significantly more likely than tortoises without lesions to have positive nasal cultures for Mycoplasma agassizii ( P =0.001) and to be dehydrated ( P =0.0007). Nine tortoises had marked azotemia (blood urea nitrogen [BUN] >100 mg/dl) or persistent azotemia (BUN 63–76 mg/dl); four of these died, three of which had necropsy confirmation of urinary tract disease. Laboratory tests had low sensitivity but high specificity in assessing morbidity and mortality; there was marked discrepancy between serologic and culture results for M. agassizii . Compared with tortoises at other sites, tortoises at DTNA were more likely to be seropositive for M. agassizii . Tortoises at Goffs were significantly more likely to have moderate to severe shell disease, oral lesions, positive nasal cultures for M. agassizii , and increased plasma aspartate aminotransferase activity. The severe disease prevalence in Goffs tortoises likely contributed to the population decline that occurred during and subsequent to this study.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Mary M. Christopher, Kristin H. Berry, Brian T. Henen, Kenneth A. Nagy. 2003. Clinical disease and laboratory abnormalities in free-ranging desert tortoises in California (1990-1995). https://doi.org/10.7589/0090-3558-39.1.35

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related USGS reports

Fipronil baits as emerging tools for flea control and plague mitigation: Experiments with cricetid mice on prairie dog colonies

Plague is a zoonotic disease of mammalian hosts and flea vectors. Wildlife biologists most commonly mitigate plague by controlling flea populations. We evaluated the efficacy of edible baits for systemic flea control with two cricetid species on colonies of black-tailed prairie dogs ( Cynomys ludovicianus ): the western deer mouse ( Peromyscus sonoriensis ) and the northern grasshopper mouse ( Onychomys leucogaster ). We tested grain bait with 0.005% fipronil by weight and “FipBit” pellets with 0.46–1.52 mg of fipronil/pellet. Flea prevalence was assessed via combing of live-trapped mice. In one experiment with fipronil grain bait and FipBits ( n =564 combings), flea prevalence declined from 74% (grain) and 45% (FipBits) before treatments to 0% for both treatments from 30–44 d and from 324–413 d after treatments. During a second experiment with FipBits ( n =299 combings), flea prevalence declined from 13% to 32% before treatments to 0% from 11–15 d after treatments, but increased to 29–56% from 349–378 d after treatments. Results herein suggest annual fipronil bait treatments may be most effective for flea control.

Journal of Wildlife Diseases↗

Toxoplasma gondii: Challenges and perspectives in interpreting longitudinal seroprevalence data for a chronic parasitic infection

Toxoplasma gondii —the causative agent of toxoplasmosis—is a zoonotic pathogen of warm-blooded hosts. Infection causes mild-to-severe symptoms, including lethargy, fever, muscle pain, abortion, ocular disease, and encephalitis. Toxoplasma affects many vertebrate species, although felids are the only known definitive hosts. Seroprevalence in wildlife is often assessed using cross-sectional data, but few studies have tracked individual-level infections through time. We present a 4-yr dataset from white-tailed deer ( Odocoileus virginianus ) with repeated sampling of individuals that highlights challenges associated with assigning serostatus to individuals. Using a modified agglutination test, we observed seroconversion from seronegative to seropositive within individuals, as expected. Although toxoplasmosis is known to be a chronic disease, we also found reversion from seropositive to seronegative. Accurate assignment of serostatus is necessary for evaluating effects of infection on behavioral and physiologic outcomes. However, longitudinal data from individuals whose titers oscillate around the positive threshold present novel challenges. Therefore, we discuss the implications for assigning serostatus for chronic toxoplasmosis infection for three proposed approaches: 1) ever positive, always positive; 2) negative until positive and then always positive; and 3) status by sampling period. Clarifying which approach is used to assign serostatus when analyzing longitudinal T. gondii data may enable more meaningful comparisons across systems and studies.

Journal of Wildlife Diseases↗

Mortality events in Yuma myotis (Myotis yumanensis) due to white-nose syndrome in Washington, USA

The impacts of white-nose syndrome (WNS) on many bat species in eastern North America have been well documented because of the length of time that the causative agent, Pseudogymnoascus destructans ( Pd ), has been present and the ability to monitor bat hibernacula in that region. However, the disease outcomes for bat species in western North America are less known because of the more recent arrival of Pd and the challenges associated with monitoring hibernating bat populations in parts of the western US. We report on mortality events involving Yuma myotis ( Myotis yumanensis ) bats at two locations in King and Benton counties, Washington, US, that were attributed to WNS during the late winters of 2020–21 and 2024, respectively. All bats that were grossly examined had depleted subcutaneous white adipose tissue, tested positive for the presence of Pd , had histopathologic lesions consistent with WNS, and did not exhibit evidence of other disease processes that may have contributed to death. Mortality was likely higher than what was documented because the locations of the Pd -contaminated hibernacula from which the bats originated were inaccessible or unknown and thus could not be surveyed. These findings indicate that Yuma myotis may be highly susceptible to WNS, and close monitoring is warranted to understand how WNS will affect population trends in this (and other) western bat species.

Washington↗